In contrast to the soluble variant, the membrane located CX3CL1 with its physiological function as adhesion molecule [18] promotes stronger adhesion of leucocytes to CX3CR1-positive cells, and therefore, might enhance T cell killing or NK cell mediated ADCC on trastuzumab coated BC tumor cells [19]. The gene discussed is CX3CL1; the disease is neoplasm.